Mercer Global Advisors
NUVB icon

Mercer Global Advisors’s Nuvation Bio NUVB Stock Holding History

Mercer Global Advisors’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$287K Buy
50,459
+13,390
+36% +$65.4K ﹤0.01% 2864
2026
Q1 		$159K Buy
37,069
+6,964
+23% +$38.8K ﹤0.01% 2909
2025
Q4 		$270K Sell
30,105
-2,013
-6% -$12.5K ﹤0.01% 2318
2025
Q3 		$119K Buy
+32,118
New +$87.5K ﹤0.01% 2493

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DFO
Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Mercer Global Advisors's NUVB Position: Q2 2026 in Review

Mercer Global Advisors increased its Nuvation Bio (NUVB) stake by 36% in Q2 2026, buying an estimated $65.4K and bringing the position to 50,459 shares worth $287K. The position accounts for ﹤0.01% of the portfolio, ranked #2864.

Mercer Global Advisors first reported a position in NUVB in Q3 2025 and has held it in 4 quarters since. 244 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

  • Mercer Global Advisors held 50,459 shares of Nuvation Bio worth $287K as of Q2 2026.
  • Mercer Global Advisors bought 13,390 Nuvation Bio shares in Q2 2026, an estimated $65.4K.
  • Nuvation Bio made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #2864 holding.
  • Mercer Global Advisors first reported a position in Nuvation Bio in Q3 2025 and has held it in 4 quarters since.
  • 244 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.